Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.66% is 56% below its 5-year average of 8.32%, around the middle of its 5-year range (-16.33%–34.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 72.57% below its 12-month average of 13.33%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.66%.
RETURN ON EQUITY (ROE)
3.66%
RETURN ON EQUITY (ROE) AVG TTM
13.33%
RETURN ON EQUITY (ROE) AVG 3Y
19.34%
RETURN ON EQUITY (ROE) AVG 5Y
8.32%
RETURN ON EQUITY (ROE) AVG 10Y
-2.82%
RETURN ON EQUITY (ROE) AVG 15Y
-7.25%
RETURN ON EQUITY (ROE) AVG 20Y
-2.07%
CURRENT VS TTM AVG
-72.57%
CURRENT VS 3Y AVG
-81.10%
CURRENT VS 5Y AVG
-56.05%
CURRENT VS 10Y AVG
+229.44%
CURRENT VS 15Y AVG
+150.46%
CURRENT VS 20Y AVG
+276.94%
SECTOR MEDIAN · HEALTHCARE
-39.55%
median of 520 covered companies
CURRENT VS SECTOR MEDIAN
+109.25%
vs the sector median at left
Alkermes plc
Market Cap
$6.95B
Return on Equity (ROE)
3.66%
TTM Avg
13.33%
3Y Avg
19.34%
5Y Avg
8.32%
Market Cap
$6.67B
Return on Equity (ROE)
33.11%
TTM Avg
27.03%
3Y Avg
27.48%
5Y Avg
31.41%
Market Cap
$7.28B
Return on Equity (ROE)
-128.44%
TTM Avg
-77.53%
3Y Avg
-74.21%
5Y Avg
-60.06%
Market Cap
$6.62B
Return on Equity (ROE)
-73.19%
TTM Avg
-58.90%
3Y Avg
-54.50%
5Y Avg
-46.46%
Market Cap
$6.53B
Return on Equity (ROE)
20.99%
TTM Avg
25.07%
3Y Avg
24.12%
5Y Avg
13.08%
Market Cap
$6.52B
Return on Equity (ROE)
-43.83%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$7.48B
Return on Equity (ROE)
31.68%
TTM Avg
-71.21%
3Y Avg
-55.91%
5Y Avg
-55.91%
Market Cap
$6.41B
Return on Equity (ROE)
476.51%
TTM Avg
2.59%
3Y Avg
-115.75%
5Y Avg
-71.67%
Market Cap
$7.59B
Return on Equity (ROE)
11.88%
TTM Avg
7.39%
3Y Avg
4.04%
5Y Avg
2.40%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alkermes plc (ALKS) | $6.95B | 3.66% | 13.33% | 19.34% | 8.32% |
| Chemed Corporation (CHE)vs › | $6.67B | 33.11% | 27.03% | 27.48% | 31.41% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.28B | -128.44% | -77.53% | -74.21% | -60.06% |
| Immunovant, Inc. (IMVT)vs › | $6.62B | -73.19% | -58.90% | -54.50% | -46.46% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | 20.99% | 25.07% | 24.12% | 13.08% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.52B | -43.83% | 25.09% | 5.57% | 0.40% |
| Hinge Health, Inc. (HNGE)vs › | $7.48B | 31.68% | -71.21% | -55.91% | -55.91% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.41B | 476.51% | 2.59% | -115.75% | -71.67% |
| HealthEquity, Inc. (HQY)vs › | $7.59B | 11.88% | 7.39% | 4.04% | 2.40% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.61B | N/A | 277.25% | 262.80% | 141.77% |
ROE
3.7%
ROA
1.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 3.66% |
| 2026-03-31 | 8.72% |
| 2025-12-31 | 13.28% |
| 2025-09-30 | 19.55% |
| 2025-06-30 | 21.45% |
| 2025-03-31 | 23.33% |
| 2024-12-31 | 25.06% |
| 2024-09-30 | 25.80% |
| 2024-06-30 | 22.49% |
| 2024-03-31 | 34.62% |
| 2023-12-31 | 29.58% |
| 2023-09-30 | 15.84% |
| 2023-06-30 | 8.04% |
| 2023-03-31 | -16.33% |
| 2022-12-31 | -15.16% |
| 2022-09-30 | -12.38% |
| 2022-06-30 | -8.70% |
| 2022-03-31 | -5.73% |
| 2021-12-31 | -4.33% |
| 2021-09-30 | -8.36% |
| 2021-06-30 | -5.72% |
| 2021-03-31 | -9.00% |
| 2020-12-31 | -10.39% |
| 2020-09-30 | -6.78% |
| 2020-06-30 | -11.90% |
| 2020-03-31 | -13.06% |
| 2019-12-31 | -18.11% |
| 2019-09-30 | -18.82% |
| 2019-06-30 | -16.73% |
| 2019-03-31 | -15.72% |
| 2018-12-31 | -11.89% |
| 2018-09-30 | -12.11% |
| 2018-06-30 | -12.19% |
| 2018-03-31 | -13.11% |
| 2017-12-31 | -13.13% |
| 2017-09-30 | -14.26% |
| 2017-06-30 | -16.28% |
| 2017-03-31 | -16.43% |
| 2016-12-31 | -17.23% |
| 2016-09-30 | -21.22% |
| 2016-06-30 | -22.12% |
| 2016-03-31 | -21.65% |
| 2015-12-31 | -17.28% |
| 2015-09-30 | -9.31% |
| 2015-06-30 | -6.16% |
| 2015-03-31 | -2.56% |
| 2014-12-31 | -2.15% |
| 2014-09-30 | -4.54% |
| 2014-06-30 | -2.10% |
| 2014-03-31 | -1.85% |
| 2013-12-31 | 0.24% |
| 2013-09-30 | 1.85% |
| 2013-06-30 | 1.01% |
| 2013-03-31 | 2.62% |
| 2012-12-31 | -4.50% |
| 2012-09-30 | -8.19% |
| 2012-06-30 | -8.84% |
| 2012-03-31 | -13.31% |
| 2011-12-31 | -7.01% |
| 2011-09-30 | -6.59% |
| 2011-06-30 | -11.52% |
| 2011-03-31 | -11.62% |
| 2010-12-31 | -11.71% |
| 2010-09-30 | -10.40% |
| 2010-06-30 | -10.62% |
| 2010-03-31 | -9.60% |
| 2009-12-31 | -9.37% |
| 2009-09-30 | 19.01% |
| 2009-06-30 | 21.24% |
| 2009-03-31 | 30.01% |
| 2008-12-31 | 27.97% |
| 2008-09-30 | 53.67% |
| 2008-06-30 | 57.18% |
| 2008-03-31 | 54.69% |
| 2007-12-31 | 49.09% |
| 2007-09-30 | 9.58% |
| 2007-06-30 | 8.48% |
| 2007-03-31 | 4.64% |
| 2006-12-31 | 5.38% |
| 2006-09-30 | 5.29% |
| 2006-06-30 | 10.26% |
| 2006-03-31 | 11.49% |
| 2005-12-31 | -68.25% |
| 2005-09-30 | -611.08% |
| 2004-12-31 | -446.60% |
| 2004-09-30 | -359.50% |
| 2004-06-30 | -266.19% |
| 2004-03-31 | -134.84% |
| 2003-12-31 | -114.04% |
| 2003-09-30 | -42.44% |
